- Cappato R, Ezekowitz MD, Klein AL, Camm AJ, Ma CS, Le Heuzey JY, Talajic M, Scanavacca M, Vardas PE, Kirchhof P, Hemmrich M, Lanius V, Meng IL, Wildgoose P, van Eickels M, Hohnloser SH; X-VeRT Investigators. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. Eur Heart J. 2014 Dec 14;35(47):3346-55. doi: 10.1093/eurheartj/ehu367. Epub 2014 Sep 2. Pubmed ID:25182247
- Retraction of: 'Cardiac paraganglioma' [Eur Heart J, doi: 10.1093/eurheartj/ehu241. Published online 18 June 2014]. Zhong Hai and Shao Guangrui. Eur Heart J. 2014 Jun 18. pii: ehu241. [Epub ahead of print] Pubmed ID:24944325
- Click here and search for drug information provided by the FDA.
- Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
- Click here to find results for studies related to Bayer Healthcare products.
- Click here to find information about studies related to Bayer Healthcare products conducted in Europe
Sources for Trial Information